{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:33Z","timestamp":1787026653060,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1526"],"award-info":[{"award-number":["CRC1526"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Epidermolysis Bullosa Acquisita (EBA) is an autoimmune blistering dermatosis characterized by autoantibodies (AAbs) against type VII collagen (COL7) located at the dermal epidermal junction (DEJ). Local complement activation drives C5a generation associated with neutrophil recruitment and activation resulting in skin lesions and inflammation. Here we tested the impact of C5a\/C5adesArg, C5 or combined C5 and alternative pathway (AP) targeting on disease development and skin inflammation in a preclinical mouse model mimicking the effector phase of EBA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>C57BL\/6 mice were treated subcutaneously with purified rabbit anti-mouse-COL7 IgG in the presence of IgG1 mAbs directed against murine C5a\/C5adesArg (M031), C5 (mBB5.1), a bifunctional protein comprising mBB5.1 fused to an active fragment of the AP inhibitor factor H (M014) or an IgG1 isotype control mAb. Formation of skin lesions was evaluated 12 days every other day. On day 12, DEJ separation, IgG AAb and C3b deposition and neutrophil infiltration was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Isotype IgG1-treated mice developed first skin lesions on day 4 peaking on day 12. Prophylactic treatment with either M031 or M014 markedly reduced the development of skin lesions, the dermal\/epidermal separation and neutrophil recruitment.  Surprisingly, C5 or combined AP\/C5 inhibition by M014 but not C5a\/C5adesArg-targeting by M031 reduced the development of skin lesions and dermal\/epidermal separation in the setting of therapeutic treatment. IgG and C3b deposition was not affected by either treatment. Importantly, direct comparison of isolated C5 targeting by mBB5.1 vs. combined AP\/C5 inhibition by M014 revealed that M014 reduced the development of skin lesions earlier and more pronounced than mBB5.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings identify combined C5\/AP targeting as a novel therapeutic option for autoimmune blistering dermatoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1560468","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:07:18Z","timestamp":1745989638000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Bj\u00f6rn","family":"Laffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Ohms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samyr","family":"Kenno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Ehlers-Jeske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"K\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)64182-x","article-title":"Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin","volume":"161","author":"Sitaru","year":"2002","journal-title":"Am J Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.973702","article-title":"The relevance of complement in pemphigoid diseases: A critical appraisal","volume":"13","author":"Papara","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13415","article-title":"In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/jci21386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Investig"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501003","article-title":"Radiosensitive hematopoietic cells determine the extent of skin inflammation in experimental epidermolysis Bullosa acquisita","volume":"195","author":"Iwata","year":"2015","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.jid.2021.12.029","article-title":"C5aR2 deficiency ameliorates inflammation in murine epidermolysis bullosa acquisita by regulating Fcgamma receptor expression on neutrophils","volume":"142","author":"Seiler","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0890-8508(87)90022-3","article-title":"Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies","volume":"1","author":"Frei","year":"1987","journal-title":"Mol Cell Probes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.55","article-title":"Drug discovery for pemphigoid diseases","volume":"84","author":"Kasprick","year":"2019","journal-title":"Curr Protoc Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128239","article-title":"Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease","volume":"4","author":"Sezin","year":"2019","journal-title":"JCI Insight"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.926044","article-title":"The complement system and ANCA associated vasculitis in the era of anti-complement drugs","volume":"13","author":"Kimoto","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/path.2857","article-title":"Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita","volume":"224","author":"Ishii","year":"2011","journal-title":"J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.3437","article-title":"C5a initiates the inflammatory cascade in immune complex peritonitis","volume":"173","author":"Godau","year":"2004","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e163105","DOI":"10.1172\/jci163105","article-title":"C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps","volume":"133","author":"Silva","year":"2023","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.07.015","article-title":"The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases","volume":"217","author":"Karsten","year":"2012","journal-title":"Immunobiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/path.4023","article-title":"Genetic identification and functional validation of Fc\u03b3RIV as key molecule in autoantibody-induced tissue injury","volume":"228","author":"Kasperkiewicz","year":"2012","journal-title":"J Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/jci119639","article-title":"A major role for neutrophils in experimental bullous pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/path.6220","article-title":"Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A\/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade","volume":"262","author":"Pigors","year":"2024","journal-title":"J Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942493","article-title":"Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients","volume":"13","author":"Emtenani","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1038\/s41467-024-50283-3","article-title":"Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2005.02.009","article-title":"Human keratinocytes produce the complement inhibitor factor H: Synthesis is regulated by interferon-\u03b3","volume":"43","author":"Tim\u00e1r","year":"2006","journal-title":"Mol Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15046","article-title":"Autoimmune bullous dermatoses","volume":"21","author":"Holtsche","year":"2023","journal-title":"JDDG: J Dtsch Dermatol Ges"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123528","article-title":"Current and innovated managements for autoimmune bullous skin disorders: an overview","volume":"11","author":"Chu","year":"2022","journal-title":"J Clin Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jid.2019.04.025","article-title":"Specific inhibition of the classical complement pathway prevents C3 deposition along the dermal-epidermal junction in bullous pemphigoid","volume":"139","author":"Freire","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2024.100307","article-title":"Treatment of bullous pemphigoid with avdoralimab: multicenter, randomized, open-labeled phase 2 study","volume":"4","author":"Passeron","year":"2024","journal-title":"JID Innov"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.1156","article-title":"Evaluation of nomacopan for treatment of bullous pemphigoid","volume":"158","author":"Sadik","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350816","article-title":"Complement-targeted therapeutics: Are we there yet, or just getting started","volume":"54","author":"Ricklin","year":"2024","journal-title":"Eur J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102416","article-title":"Thrombosis and meningococcal infection rates in pegcetacoplan-treated patients with paroxysmal nocturnal hemoglobinuria in the clinical trial and postmarketing settings","volume":"8","author":"Kelly","year":"2024","journal-title":"Res Pr Thromb Haemost"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00926-0","article-title":"Dynamic regulation of B cell complement signaling is integral to germinal center responses","volume":"22","author":"Cumpelik","year":"2021","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124646","article-title":"C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans","volume":"3","author":"Verghese","year":"2018","journal-title":"JCI Insight"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900276","article-title":"Follicular B2 cell activation and class switch recombination depend on autocrine C3ar1\/C5ar1 signaling in B2 cells","volume":"203","author":"Paiano","year":"2019","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.152.4.1102","article-title":"Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement","volume":"152","author":"Pangburn","year":"1980","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700734","article-title":"Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum","volume":"32","author":"Lachmann","year":"2017","journal-title":"FASEB J : Off Publ Fed Am Soc Exp Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2005.06.020","article-title":"Complement amplification revisited","volume":"43","author":"Lutz","year":"2006","journal-title":"Mol Immunol"},{"key":"B46","article-title":"Complement fixation by the F(ab\u2019)2-fragment of pepsin-treated rabbit antibody","volume":"20","author":"Reid","year":"1971","journal-title":"Immunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0167-5699(98)01376-0","article-title":"Does properdin crosslink the cellular and the humoral immune response","volume":"20","author":"Schwaeble","year":"1999","journal-title":"Immunol Today"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:07:19Z","timestamp":1745989639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1560468"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1560468","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"1560468"}}